| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60f67cf07e3fdc9c7d98b1c36039ec12 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 |
| filingDate |
2012-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_867530a40c52aee04b285229d38b69b4 |
| publicationDate |
2013-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201322985-A |
| titleOfInvention |
Prevention of adverse effects caused by EpCAMxCD3 bispecific antibody |
| abstract |
The present invention relates to a glucocorticoid (GC) for use in ameliorating, treating and/or preventing liver and/or gastrointestinal adverse events caused by an EpCAMxCD3 bispecific antibody, wherein administration of the GC is initiated prior to administration of the EpCAMxCD3 bispecific antibody . Also included are kits comprising a GC, EpCAMxCD3 bispecific antibody and instructions for use of the liver and/or gastrointestinal adverse events caused by the EpCAMxCD3 bispecific antibody to be used in the treatment, amelioration and/or prevention of the GC. |
| priorityDate |
2011-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |